Stories

Responsible vape retailers should not face the same treatment as businesses selling illegal products, the UK Vaping Industry Association has told MPs.

The UKVIA is calling for stronger licensing, tougher enforcement and meaningful penalties against rogue traders, alongside recognition of specialist vape shops that provide age-verified access and advice to adult smokers.

With approximately 3.3 million former smokers now vaping in Great Britain, the distinction matters for tobacco harm reduction. Effective regulation should tackle illicit sales and protect young people while preserving responsible retail channels that support adults moving away from cigarettes.

Canada's pharmacy-only model for nicotine pouches has created an unusual regulatory imbalance. Since 2024, authorised pouches have been restricted to pharmacy sales, while unauthorised products remain widely available through online and retail channels.

At GFN 2026, pharmacist Todd Prochnau examined the practical consequences of this approach, including barriers to access, additional pressure on pharmacists and inconsistent risk communication.

The experience raises important questions about whether restricting regulated smoke-free alternatives supports smoking cessation or unintentionally strengthens the illicit market. Effective tobacco harm reduction requires both appropriate safeguards and realistic consumer access.

A new study in JAMA Cardiology examining vascular function and cardiovascular fitness among young adults who vape has drawn criticism from leading researchers over significant methodological limitations.

With just 17 vapers and 19 smokers included, experts warn that the findings cannot establish causation or demonstrate equivalent cardiovascular risks between vaping and smoking. Differences in participants’ smoking histories, physical activity and lifestyle factors further complicate interpretation.

The expert responses underline the importance of robust study design and accurate risk communication, particularly as stronger evidence suggests that switching completely from smoking to vaping can reduce cardiovascular harm.

Australia’s smoking statistics are raising new questions about the effectiveness of its tobacco control policies. The 2026 Wesfarmers Health Index estimates daily smoking at 10.1%, considerably higher than the government's reported figure of 5.6%, although differences in survey methods may explain part of the gap.

The discrepancy highlights the need for transparent data and closer examination of smoking trends, particularly among disadvantaged communities. Beyond measuring declining prevalence, Australia must ensure that adults who continue to smoke have access to effective cessation support and regulated, lower-risk nicotine alternatives.

Nicotine use among American teenagers may be at its lowest level in 50 years, according to an analysis of long-term national survey data by Charles A. Gardner.

Youth cigarette smoking has declined dramatically, while vaping has also fallen substantially in recent years. Although differences in historical survey methods make the exact 50-year comparison uncertain, the overall downward trend is clear.

These findings offer important context for tobacco harm reduction, highlighting the need to recognise progress in youth prevention while maintaining access to lower-risk alternatives for adults who smoke.

Pennsylvania's new nicotine regulations under Act 57 could significantly restrict access to smoke-free alternatives, with only 159 products included on the state's approved list.

The Taxpayers Protection Alliance warns that these restrictions may limit consumer choice, affect small retailers and encourage illicit trade. With around 1.4 million adults smoking in Pennsylvania, the potential consequences for tobacco harm reduction deserve attention. Effective regulation should balance product safety and youth protection with access to lower-risk alternatives for adults seeking to quit smoking.

Research from the University of Stirling examining restrictions on retail displays of vapes and nicotine pouches has prompted criticism over its focus on reducing product appeal without assessing potential consequences for smoking cessation.

Making smoke-free alternatives less visible may discourage adult smokers from considering products that could help them quit cigarettes. The debate highlights an important gap between measuring consumer perceptions and evaluating actual public health outcomes. Tobacco control research should consider both youth protection and the potential impact of restrictions on harm reduction.